A Pilot study on clinical efficacy of Deva Chooranam along with concomitant antiretroviral theraphy among HIV patients

A Pilot study on clinical efficacy of Deva Chooranam along with concomitant antiretroviral theraphy among HIV patients - HIV

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/012909

Enrollment

Registered

2018-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- HIV

Interventions

Intervention1: Deva Chooranam: 3 gram of deva chooranam will be given orally twice a day along with cows milk for a period of 90 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1)HIV test positive in Elisa and confirm by Western Blot method 2)Below normal range of CD4 counts (200-500 cells) 3)Patients willing to give biological samples whenever necessary 4)Patients willing to take Deva chooranam along with Anti Retroviral Theraphy

Exclusion criteria

Exclusion criteria: 1)pregnancy 2)coronary heart disease 3)hepatitis,cirrhosis of liver,Neuro tuberculosis 4)patients not giving informed consent 5)meningitis 6)chronic kidney disease

Design outcomes

Primary

Measure	Time frame
1)Improvement in CD4 counts 2)Improving quality of life in AIDS patientsTimepoint: 1)Improvement in CD4 counts 2)Improving quality of life in AIDS patients	—

Secondary

Measure	Time frame
1)Changes in other laboratory parameters 2)Justification of traditional claims through preclinical and clinical studies 3)Assessment of quality of lifeTimepoint: 90 DAYS	—

Countries

India

Contacts

Public ContactDr K Thangadurai

National Institute Of Siddha,Tambaram Sanatorium,chennai

24gold1971@gmail.com9843023292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026